The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer

Valentini, V., Gambacorta, M. A., Cellini, F., Aristei, C., Coco, C., Barbaro, B., Alfieri, S., D'Ugo, D., Persiani, R., Deodato, F., Crucitti, A., Lupattelli, M., Mantello, G., Navarria, F., Belluco, C., Buonadonna, A., Boso, C., Lonardi, S., Caravatta, L., Barba, M. C., Vecchio, F. M., Maranzano, E., Genovesi, D., Doglietto, G. B., Morganti, A. G., La Torre, G., Pucciarelli, S., De Paoli, A., The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer, <>, 2019; 134 (N/A): 110-118. [doi:10.1016/j.radonc.2018.11.023] [http://hdl.handle.net/10807/148642]